BRKR Stock Declines Despite Launching EpicIF Technology for CellScape

Bruker Corporation (BRKR) recently announced a new technology, EpicIF (Enhanced photobleaching in cyclic immunofluorescence), to further enhance the CellScape Precise Spatial Proteomics platform for highly multiplexed immunofluorescence (IF).The new technology is likely to enhance the CellScape platform by expanding antibody compatibility and doubling throughput while maintaining tissue integrity and lack of cross-reactivity.Likely Trend of BRKR Stock Following the NewsFollowing the announcement, shares of ...